rs10626847
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_004115.4(FGF14):c.*1387_*1390dupTAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.39 ( 11778 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
FGF14
NM_004115.4 3_prime_UTR
NM_004115.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.02
Publications
1 publications found
Genes affected
FGF14 (HGNC:3671): (fibroblast growth factor 14) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. A mutation in this gene is associated with autosomal dominant cerebral ataxia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
FGF14 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia 27AInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 27Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- autosomal recessive cerebellar ataxiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 13-101721440-C-CTTTA is Benign according to our data. Variant chr13-101721440-C-CTTTA is described in ClinVar as Benign. ClinVar VariationId is 310867.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004115.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FGF14 | MANE Select | c.*1387_*1390dupTAAA | 3_prime_UTR | Exon 5 of 5 | NP_004106.1 | Q92915-1 | |||
| FGF14 | c.*1387_*1390dupTAAA | 3_prime_UTR | Exon 5 of 5 | NP_787125.1 | Q92915-2 | ||||
| FGF14 | c.*1387_*1390dupTAAA | 3_prime_UTR | Exon 4 of 4 | NP_001308868.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FGF14 | TSL:1 MANE Select | c.*1387_*1390dupTAAA | 3_prime_UTR | Exon 5 of 5 | ENSP00000365313.4 | Q92915-1 | |||
| FGF14 | TSL:1 | c.*1387_*1390dupTAAA | 3_prime_UTR | Exon 5 of 5 | ENSP00000365301.3 | Q92915-2 | |||
| FGF14 | n.*1735_*1738dupTAAA | non_coding_transcript_exon | Exon 6 of 6 | ENSP00000516413.1 | A0A9L9PXI9 |
Frequencies
GnomAD3 genomes AF: 0.387 AC: 58649AN: 151368Hom.: 11772 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
58649
AN:
151368
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.387 AC: 58676AN: 151486Hom.: 11778 Cov.: 0 AF XY: 0.382 AC XY: 28291AN XY: 73994 show subpopulations
GnomAD4 genome
AF:
AC:
58676
AN:
151486
Hom.:
Cov.:
0
AF XY:
AC XY:
28291
AN XY:
73994
show subpopulations
African (AFR)
AF:
AC:
12223
AN:
41358
American (AMR)
AF:
AC:
5434
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
AC:
1500
AN:
3464
East Asian (EAS)
AF:
AC:
2628
AN:
5086
South Asian (SAS)
AF:
AC:
2313
AN:
4788
European-Finnish (FIN)
AF:
AC:
3768
AN:
10488
Middle Eastern (MID)
AF:
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29320
AN:
67784
Other (OTH)
AF:
AC:
869
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1764
3528
5292
7056
8820
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1835
AN:
3478
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
Autosomal dominant cerebellar ataxia (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.